Home > Drug Search >
  • Bio-Type: Recombinant coagulation factor
  •   > 
Drug Filter
Status:
Approved (22) BLA Filing (3) Phase Ⅲ (3) Phase Ⅱ (2) Phase Ⅰ (6)
Clinical Stage:
Active (11) Discontinued (3)
Company:
Ipsen (1) Janssen (1) MedImmune (1) Novo Nordisk (5) Pfizer (3) Portola Pharmaceutical (1) Sanofi (1) SOBI (1) Xenetic Biosciences (1) Kaketsuken (1) Alphamab (1) International Biotech Center Generium (3) AryoGen Biopharma (1) Recoly (2) Tonrol (1) rEVO Biologics (1) Inspiration Biopharmaceuticals (1) Emergent (1) Octapharma (1) Green Cross (1) Aventis (1) Baxalta (9) CSL Behring (1) CSL (1) Bayer (2) Chiatai Tianqing (CTTQ) (1)
Indication:
Acute myeloid Leukemia (AML) (1) Hemophilia A (20) Hemophilia B (10) Congenital factor VII deficiency (2) Acquired hemophilia (1) Glanzmann’s thrombasthenia (2) Congenital factor XIII A-subunit deficiency (1) Hemorrhagic disorder (1) Bleeding (1) Thrombosis (1) Von Willebrand disease (1) Acquired thrombotic thrombocytopenic purpura (1) Hemophilia (3) Cerebral haemorrhage (1)
Country:
Aprv. Year:
1995 (1) 1999 (1) 2003 (1) 2013 (1) 2014 (2) 2015 (3) 2016 (1) 2017 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top